Skip to content

Clinical trials

Atherosclerosis trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: New Zealand Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20111
20122
20131
20141
20151
20171
20182
20201
20211
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation5
GlaxoSmithKline3
Verve Therapeutics, Inc.2
480 Biomedical1
Abbott Medical Devices1
AstraZeneca1
C. R. Bard1
CSL Behring1
Eli Lilly and Company1
Klinikum Rosenheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis20
Cardiovascular Diseases9
Coronary Artery Disease5
Peripheral Arterial Disease5
Heart Diseases4
Hypercholesterolemia4
Acute Coronary Syndrome2
Arterial Occlusive Diseases2
Coronary Disease2
Hyperlipoproteinemia Type II2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.